Details: name of work: re-tender for the procurement of anticancer drugs for the year 2024-25item description2cabozantinib tab 20mgcetuximab inj 100mgcyclophosphamide tab ip 50mgdactinomycin inj 0.5 mg/3mldaunorubicin inj ip 20mgenzalutamide cap 80 mgexemestane tab ip 25 mgibandronate tab 50 mgmegestrol acetate tab ip/bp/usp 40 mgmercaptopurine tab ip 50 mgmethotrexate inj (intrathecal, preservative free) 15mgmethotrexate tab ip 2.5mgmitomycin for inj ip/usp 10 mgmitoxantrone infusion bp/usp 20 mgpomalidomide cap 2 mgprocarbazine hcl cap ip 50 mgrasburicase inj 1.5 mgregorafenib tab 40 mgrucaparib tab 300 mgtegafur +uracil cap 100 mg + 224vinblastine sulphate inj ip 10mgcyclophosphamide inj ip 200mgcyclophosphamide inj ip 500mgcyclophosphamide inj ip 1 gmdecitabine inj 30mgeverolimus tab 10 mgeverolimus tab 5mgflurouracil inj ip 500mgflurouracil inj ip 250mgifosfamide with mesna inj 1gmifosfamide with mesna inj 2gmleucovorin calcium inj ip 15mgmethotrexate inj ip 500 mgnilotinib cap 150 mgnil
Sector: Medical and Health